2020
DOI: 10.14744/nci.2020.93195
|View full text |Cite
|
Sign up to set email alerts
|

A meta-analysis of antibiotic resistance rates in Pseudomonas aeruginosa isolated in blood cultures in Turkey between 2007 and 2017

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…The researchers concluded that the prevalence of antibiotic resistance in pathogenic strains of P. aeruginosa in Turkey is considerably high and continues to rise compared to previous years (13). Imipenem and meropenem resistance rate in P.aeruginosa was found as 26.8% and 25.1%, respectively, according to a meta-analysis performed by Işık et al The authors concluded frequency of P. aeruginosa strains resistant to carbapenems has dramatically risen in Turkey as a direct result of the extensive usage of these antibiotics (14). P.aeruginosa was determined one of the most frequently bacteriae identified from respiratory tract samples, and 43% of these isolates were susceptible to imipenem and 34.5% to meropenem in 2021 (15).…”
Section: Discussionmentioning
confidence: 99%
“…The researchers concluded that the prevalence of antibiotic resistance in pathogenic strains of P. aeruginosa in Turkey is considerably high and continues to rise compared to previous years (13). Imipenem and meropenem resistance rate in P.aeruginosa was found as 26.8% and 25.1%, respectively, according to a meta-analysis performed by Işık et al The authors concluded frequency of P. aeruginosa strains resistant to carbapenems has dramatically risen in Turkey as a direct result of the extensive usage of these antibiotics (14). P.aeruginosa was determined one of the most frequently bacteriae identified from respiratory tract samples, and 43% of these isolates were susceptible to imipenem and 34.5% to meropenem in 2021 (15).…”
Section: Discussionmentioning
confidence: 99%